Back to results
US 8,273,771 B2Granted
Ischemic disorder or disease inhibitors
AssigneePronas Pharma AB
InventorsLars Edvinsson, Saema Ansar
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of at least on inhibitor selected from the group consisting of raf-, protein kinase C (PKC)-, MEK1/2-, or ERK1/2-inhibitors, for the manufacturing of a medicament to be administrated from 1 up to 12 hours after initiation of an ischemic disease.
Claims11
A method of treating a patient for ischemic damage, comprising:
- administering a medicament comprising at least one inhibitor selected from the group consisting of U0126, SB590885, and SB386023b to the patient to reduce the ischemic damage, wherein said medicament is administered to the patient from greater than 1 hour up to 12 hours after onset of the ischemic damage.
Dependencies are inferred from the claim text.